SOM Biotech will attend the First European Congress on Hereditary ATTR Amyloidosis to be held in Paris, from November 2nd – 3rd 2015. SOM Biotech team will present the preliminary results of Phase 2a clinical trial with SOM0226 on ATTR Amyloidosis, which has recently been successfully completed.

For further information please visit



    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.